학술논문
Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel–treated patients in the TRANSCEND NHL 001 trial
Document Type
Article
Author
Source
In Blood Advances 23 March 2021 5(6):1695-1705
Subject
Language
ISSN
2473-9529